Strides Pharma Science Stock Screener | Share Price & Fundamental Analysis
STAR
Pharmaceuticals
Share Price NSE
₹964.40
▼
-29.70 (-2.99%)
Share Price BSE
₹967.10
▼
-27.10 (-2.73%)
Track Strides Pharma Science share price live with TickJournal's free stock screener.
Analyze Strides Pharma Science share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Strides Pharma Science Market Cap
₹8,951.35 Cr.
STAR P/E Ratio (TTM)
16.77
Strides Pharma Science P/B Ratio
3.23
EPS (TTM)
₹390.55
Dividend Yield
0.41%
Debt to Equity
0.94
STAR 52 Week High
₹994.10
Strides Pharma Science 52 Week Low
₹615.30
Operating Margin
19.00%
Profit Margin
15.98%
STAR Revenue (TTM)
₹1,302.00
EBITDA
₹340.00
Net Income
₹208.00
Total Assets
₹6,049.00
Total Equity
₹2,587.00
Strides Pharma Science Share Price History - Stock Screener Chart
Screen STAR historical share price movements with interactive charts. Analyze price trends and patterns.
Strides Pharma Science Company Profile - Fundamental Screener
Screen Strides Pharma Science company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for STAR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE939A01011
Strides Pharma Science Balance Sheet Screener
Screen STAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 6,049 | 5,840 | 6,638 | 6,976 | 7,015 | 6,152 | 7,980 | 6,708 | 8,105 | 7,659 |
| Current Assets | 3,099 | 2,969 | 3,243 | 3,362 | 2,817 | 2,372 | 3,049 | 2,484 | 3,792 | 3,595 |
| Fixed Assets | 1,899 | 1,865 | 2,311 | 2,347 | 2,219 | 2,099 | 3,648 | 2,977 | 2,980 | 2,499 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 871 | 889 | 1,475 | 1,181 | 1,463 | 1,012 | 2,516 | 2,191 | 2,119 | 2,813 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 2,587 | 2,072 | 2,173 | 2,383 | 2,814 | 2,595 | 2,802 | 2,618 | 2,882 | 2,906 |
| Share Capital | 92 | 92 | 90 | 90 | 90 | 90 | 90 | 90 | 89 | 89 |
| Reserves & Surplus | 2,460 | 2,034 | 2,105 | 2,269 | 2,687 | 2,438 | 2,559 | 2,374 | 2,659 | 2,774 |
Strides Pharma Science Income Statement Screener - Profit & Revenue Analysis
Screen Strides Pharma Science income statement and profit fundamentals.
Analyze STAR quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Strides Pharma Science share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Mar | 2025-Jun | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,302 | 1,248 | 1,206 | 1,128 | 1,030 | 4,354 | 1,195 | 1,160 | 1,014 | 939 | 1,035 | 1,075 | 952 | 954 | 954 |
| Expenses | 962 | 999 | 1,000 | 910 | 888 | 866 | 987 | 946 | 879 | 802 | 1,054 | 886 | 944 | 1,002 | 844 |
| EBITDA | 340 | 249 | 206 | 218 | 142 | 3,488 | 209 | 215 | 135 | 136 | -18 | 189 | 8 | -49 | 110 |
| Operating Profit % | 19.00% | 18.00% | 16.00% | 19.00% | 15.00% | 18.00% | 15.00% | 18.00% | 11.00% | 14.00% | -5.00% | 12.00% | -9.00% | -7.00% | 6.00% |
| Depreciation | 51 | 50 | 49 | 49 | 48 | 47 | 49 | 48 | 61 | 60 | 60 | 49 | 61 | 60 | 62 |
| Interest | 43 | 46 | 50 | 48 | 71 | 73 | 74 | 52 | 81 | 76 | 79 | 70 | 50 | 55 | 68 |
| Profit Before Tax | 246 | 153 | 106 | 122 | 23 | 3,369 | 86 | 114 | -7 | 0 | -157 | 70 | -103 | -163 | -20 |
| Tax | 37 | 22 | 21 | 17 | 13 | 19 | 14 | 24 | 7 | 10 | -7 | 16 | -132 | -28 | -38 |
| Net Profit | 208 | 132 | 86 | 106 | 10 | 3,350 | 72 | 90 | -14 | -9 | -150 | 54 | 29 | -135 | 19 |
| EPS | 21.93 | 13.84 | 8.92 | 10.81 | 1.98 | 364.64 | 7.81 | 9.56 | -1.06 | -0.79 | -14.54 | 5.43 | 3.25 | -15.13 | 2.54 |
Strides Pharma Science Cash Flow Screener - Liquidity Fundamentals
Screen STAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 684 | 701 | 44 | -258 | 481 | 205 | 60 | 187 | 288 | 73 |
| Investing Activities | -90 | -150 | 302 | -119 | -522 | 1,321 | -145 | 570 | -1,222 | -2,205 |
| Financing Activities | -643 | -693 | -214 | 421 | -16 | -1,709 | 194 | -1,016 | 338 | 2,944 |
| Net Cash Flow | -49 | -143 | 133 | 45 | -56 | -184 | 110 | -259 | -596 | 812 |
Strides Pharma Science Shareholding Pattern Screener
See Strides Pharma Science shareholding pattern with promoter, FII, and DII holdings.
Check Strides Pharma Science promoter holding and ownership changes for STAR on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 27.86% | 27.86% | 28.30% | 28.30% | 26.82% | 25.84% | 25.86% | 25.88% |
| FII Holding | 29.52% | 28.51% | 28.02% | 28.32% | 28.48% | 30.08% | 26.71% | 24.57% |
| DII Holding | 13.02% | 12.98% | 13.30% | 13.72% | 16.92% | 18.24% | 18.56% | 18.04% |
| Govt Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public Holding | 21.42% | 22.44% | 22.10% | 21.52% | 20.86% | 18.57% | 20.87% | 21.19% |
| Other Holding | 8.17% | 8.20% | 8.27% | 8.14% | 6.90% | 7.26% | 8.00% | 10.32% |
| Shareholder Count | 85,589 | 91,206 | 92,889 | 95,125 | 114,236 | 96,009 | 91,917 | 84,695 |
Strides Pharma Science Share Dividend Screener - Share Yield Analysis
Check Strides Pharma Science dividend history with payout and yield data.
View Strides Pharma Science dividend details including ex-dates and amounts for STAR stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹4.00 | 0.43% |
| 2024-March | ₹2.50 | 0.37% |
| 2023-March | ₹1.50 | 0.19% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹2.50 | 0.72% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹3.00 | 0.93% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Strides Pharma Science Stock Index Membership
See which indices include Strides Pharma Science stock.
Check STAR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
Strides Pharma Science Market Events Screener - Corporate Actions
Get Strides Pharma Science corporate actions including splits, bonuses, and buybacks.
Check Strides Pharma Science stock events that may affect STAR share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Extraordinary General Meeting | NA | 17.24% | ||
| Annual General Meeting | NA | 2.34% | ||
| Dividend | ₹ 2.50 /share | 60.70% | ||
| 2026-01-30 | 2026-01-30 | Quarterly Result Announcement | NA | -6.46% |
| 2025-10-31 | 2025-10-31 | Quarterly Result Announcement | NA | 3.90% |
| 2025-08-07 | 2025-08-07 | Annual General Meeting | NA | -6.92% |
| 2025-07-29 | 2025-07-29 | Quarterly Result Announcement | NA | 5.08% |
| 2025-07-22 | 2025-07-22 | Dividend | ₹ 4.00 /share | 28.02% |
| 2025-05-22 | 2025-05-22 | Quarterly Result Announcement | NA | 4.76% |
| 2025-01-30 | 2025-01-30 | Quarterly Result Announcement | NA | -3.10% |
| 2024-10-24 | 2024-10-24 | Quarterly Result Announcement | NA | -5.05% |
| 2023-08-28 | 2023-08-28 | Annual General Meeting | NA | -0.09% |
| 2023-08-04 | 2023-08-04 | Dividend | ₹ 1.50 /share | 17.50% |
| 2021-08-05 | 2021-08-06 | Dividend | ₹ 2.50 /share | -3.83% |
| 2018-07-18 | 2018-07-18 | Change Of Name | NA | 0.00% |
Strides Pharma Science Competitors Screener - Peer Comparison
Screen STAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 406,351 | 37.86 | 54,729 | 9.71% | 10,980 | 37.98 |
| Divis Laboratories | 155,472 | 63.26 | 9,712 | 18.67% | 2,191 | 33.24 |
| Torrent Pharmaceuticals | 134,945 | 61.20 | 11,539 | 6.99% | 1,911 | 32.75 |
| Lupin | 103,954 | 22.26 | 22,910 | 13.74% | 3,306 | 47.35 |
| Dr Reddys Laboratories | 101,601 | 18.27 | 33,741 | 16.73% | 5,725 | 39.36 |
| Cipla | 96,320 | 21.31 | 28,410 | 7.12% | 5,291 | 26.86 |
| Zydus Life Science | 86,964 | 17.29 | 23,511 | 18.55% | 4,615 | 41.42 |
| Mankind Pharma | 82,499 | 45.81 | 12,744 | 20.90% | 2,007 | 41.40 |
| Aurobindo Pharma | 77,462 | 22.37 | 32,346 | 9.43% | 3,484 | 64.38 |
| Alkem Laboratories | 62,867 | 25.87 | 13,458 | 3.70% | 2,216 | 42.54 |
Strides Pharma Science Company Announcements - News Screener
Screen STAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-31 | Closure of Trading Window | - |
| 2026-03-17 | Disclosure Under Regulation 30 Of SEBI Listing Regulations | - |
| 2026-03-17 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-17 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-02-05 | Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) | - |
| 2026-02-05 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-02-02 | Response To Query Dated Feb 1 2026 - Clarification On Volume Movement In The Equity Shares Of The Company | - |
| 2026-02-01 | Clarification sought from Strides Pharma Science Ltd | - |
| 2026-01-31 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-01-30 | Board Meeting Outcome for Outcome Of Board Meeting - Financial Results Q3 FY 26 | - |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-01-30 | Un-Audited Financial Results (Consolidated & Standalone) For The Quarter And Nine Months Ended December 31 2025 | - |
| 2026-01-23 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-01-23 | Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-01-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |